FdaApplication
NDA 021479
Identifiers
- fda_app_no: NDA021479
Properties
| Property | Value |
|---|---|
| applicant_name | BAUSCH HEALTH US LLC |
| application_type | NDA |
| approval_date | 2006-06-14 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ZELAPAR | SELEGILINE HYDROCHLORIDE | 1.25MG | TABLET, ORALLY DISINTEGRATING;ORAL |
1 product